|
Sep 16
|
5 Things to Know Before the Stock Market Opens
|
|
Sep 15
|
Is Pfizer's 5.7% Dividend Yield Worth the Risk?
|
|
Sep 14
|
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
|
|
Sep 14
|
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
|
|
Sep 13
|
Pfizer Inc. (PFE): A Bull Case Theory
|
|
Aug 30
|
Pfizer. Inc. (PFE): One of the Best Affordable Stocks Under $40 According to Short Sellers
|
|
Aug 30
|
Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
|
|
Aug 30
|
US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
|
|
Aug 30
|
Pharma Stock Roundup: LLY Offers Cheap Zepbound, EU Okays Some Drugs
|
|
Aug 30
|
DMD clinical studies evolve with emphasis on building designs around relevant endpoints
|
|
Aug 30
|
Novo builds heart failure case for semaglutide; Ventyx CFO departs
|
|
Aug 30
|
2 Incredibly Cheap Growth Stocks to Buy Now
|
|
Aug 29
|
GSK's RSV Vaccine Arexvy Gets EU Nod for Adults Aged 50-59 Years
|
|
Aug 29
|
New COVID vaccines are here. What to know about the latest shots as summer surge continues
|
|
Aug 29
|
Why Is Pfizer (PFE) Down 5.9% Since Last Earnings Report?
|
|
Aug 29
|
Flagship, Quotient and Pfizer link on cardiovascular and renal disease
|
|
Aug 28
|
Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs
|
|
Aug 28
|
2 Beaten-Down S&P 500 Dividend Stocks to Buy on the Dip and Hold Forever
|
|
Aug 28
|
Pfizer launches digital healthcare platform to streamline access
|
|
Aug 27
|
Why Walgreens Boots Alliance Plunged Today
|